Telesis Bio (NASDAQ:TBIO) reported its Q1 earnings results on Thursday, May 11, 2023 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
Telesis Bio reported in-line EPS of $-0.37 versus an estimate of $-0.37.
Revenue was up $680 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.13 which was followed by a 9.95% drop in the share price the next day.
Here’s a look at Telesis Bio’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.41 | -0.48 | -0.51 | -0.45 |
| EPS Actual | -0.28 | -0.42 | -0.50 | -0.45 |
| Revenue Estimate | 7.20M | 5.30M | 4.45M | 3.90M |
| Revenue Actual | 9.47M | 6.67M | 5.66M | 5.64M |
To track all earnings releases for Telesis Bio visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
